Re: Ketoconazole Therapy for Fungal Urinary Tract Infections, by J. R. Graybill, J. N. Galgiani, J. H. Jorgensen and D. A. Strandberg, J. Urol., 129: 68–70, 1983

Autor: P. J. Kozinn, Gilbert J. Wise, Claire L. Taschdjian

Publikováno v: Journal of Urology. 131:127-128

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0cb420de4bebd9bf8ea7b8c4806e340d
https://doi.org/10.1016/s0022-5347(17)50242-6

A randomized, double-blind, placebo-controlled clinical trial of fluconazole as early empiric treatment of coccidioidomycosis pneumonia (Valley Fever) in adults presenting with community-acquired pneumonia in endemic areas (FLEET-Valley Fever).

Autor: Messina JA; Duke University School of Medicine, Durham, NC, USA., Maziarz EK; Duke University School of Medicine, Durham, NC, USA., Galgiani J; Valley Fever Center for Excellence, University of Arizona, Tucson, AZ, USA., Truong JT; Southern California Kaiser Permanente, Antelope Valley, CA, USA., Htoo AK; Southern California Kaiser Permanente, Kern County, CA, USA., Heidari A; Valley Fever Institute, Kern Medical, Bakersfield, CA, USA., Johnson RH; Valley Fever Institute, Kern Medical, Bakersfield, CA, USA., Narang AT; Banner University Medical Center Phoenix, Phoenix, AZ, USA., Donovan FM; Banner University Medical Center Tuscon, Tuscon, AZ, USA., Ewell M; Emmes, Rockville, MD, USA., Catanzaro A; University of California San Diego Medical Center, San Diego, CA, USA., Thompson GR 3rd; University of California Davis School of Medicine, Sacramento, CA, USA., Ampel NM; University of Arizona, Tucson, AZ, USA., Perfect JR; Duke University School of Medicine, Durham, NC, USA., Naggie S; Duke University School of Medicine, Durham, NC, USA.; Duke Clinical Research Institute, Durham, NC, USA., Walter EB; Duke University School of Medicine, Durham, NC, USA.; Duke Clinical Research Institute, Durham, NC, USA.; Duke Human Vaccine Institute, Durham, NC, USA.

Publikováno v: Contemporary clinical trials communications [Contemp Clin Trials Commun] 2021 Oct 14; Vol. 24, pp. 100851. Date of Electronic Publication: 2021 Oct 14 (Print Publication: 2021).

Clinical Characteristics and Mortality Risks Among Patients With Culture-Proven Coccidioidomycosis Who Are Critically Ill: A Multicenter Study in an Endemic Region.

Autor: Lim, James^1,2 (AUTHOR), Scott, Ashley M¹ (AUTHOR), Wig, Rebecca¹ (AUTHOR), Tan, Rachel V¹ (AUTHOR), Harnois, Emily R¹ (AUTHOR), Zangeneh, Tirdad T^1,2,3 (AUTHOR), Al-Obaidi, Mohanad M^1,2,3 (AUTHOR) alobaidim@arizona.edu

Publikováno v: Open Forum Infectious Diseases. Aug2024, Vol. 11 Issue 8, p1-6. 6p.

Introduction to the forum report on advances in the design of antifungal clinical trials

Autor: Bennet, Je, De Pauw, B, Dismukes, W, Galgiani, J, Glauser, M, Herbrecht, R, Kauffman, C, Lee, J, Pappas, P, Power, J, Rex, J, Verweij, Viscoli, Claudio, Walsh, T.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3710::3418a33d7ecfe9d21c8c1f120a378f07
http://hdl.handle.net/11567/390376

Forum report: issues in the design of trials of drugs for the treatment of invasive aspergillosis

Autor: Bennett, J.E., Powers, J., de Pauw, B., Dismukes, W., Galgiani, J., Glauser, M., Herbrecht, R., Kauffman, C., Lee, J., Pappas, P., Rex, J., Verweij, P., Viscoli, C., Walsh, T.

Publikováno v: Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 36, no. Suppl 3, pp. S113-S116

A recent trial of drugs for invasive aspergillosis was used as a background for discussing critical features in the design of antifungal trials. The study under discussion allowed stopping either drug without classifying the patient as having treatme

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1900::6e97a7fdd6b2638efd89e5a9f9cc1375
https://serval.unil.ch/resource/serval:BIB_01F1CF8A0F47.P001/REF.pdf